Authors:
Booij, J
Bergmans, P
Winogrodzka, A
Speelman, JD
Wolters, EC
Citation: J. Booij et al., Imaging of dopamine transporters with [I-123]FP-CIT SPECT does not suggesta significant effect of age on the symptomatic threshold of disease in Parkinson's disease, SYNAPSE, 39(2), 2001, pp. 101-108
Authors:
Winogrodzka, A
Wagenaar, RC
Bergmans, P
Vellinga, A
Booij, J
van Royen, EA
van Emmerik, REA
Stoof, JC
Wolters, EC
Citation: A. Winogrodzka et al., Rigidity decreases resting tremor intensity in Parkinson's disease: A [I-123]beta-CIT SPECT study in early, nonmedicated patients, MOVEMENT D, 16(6), 2001, pp. 1033-1040
Authors:
Winogrodzka, A
Bergmans, P
Booij, J
van Royen, EA
Janssen, AGM
Wolters, EC
Citation: A. Winogrodzka et al., [I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease, J NEURAL TR, 108(8-9), 2001, pp. 1011-1019
Authors:
Booij, J
Tissingh, G
Winogrodzka, A
van Royen, EA
Citation: J. Booij et al., Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism, EUR J NUCL, 26(2), 1999, pp. 171-182
Authors:
Stoof, JC
Winogrodzka, A
van Muiswinkel, FL
Wolters, EC
Voorn, P
Groenewegen, HJ
Booij, J
Drukarch, B
Citation: Jc. Stoof et al., Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy, EUR J PHARM, 375(1-3), 1999, pp. 75-86